Cargando…
JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
BACKGROUND: Innate immune cells play a crucial role in the pathophysiology of rheumatoid arthritis (RA) via release of cytokines. Small-molecule inhibitors of Janus kinases (JAKi) are clinically efficacious in patients with RA. However, the isoform-specific action of each JAKi is difficult to assess...
Autores principales: | Fujita, Yuya, Matsuoka, Naoki, Temmoku, Jumpei, Furuya-Yashiro, Makiko, Asano, Tomoyuki, Sato, Shuzo, Matsumoto, Haruki, Watanabe, Hiroshi, Kozuru, Hideko, Yatsuhashi, Hiroshi, Kawakami, Atsushi, Migita, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296727/ https://www.ncbi.nlm.nih.gov/pubmed/32539713 http://dx.doi.org/10.1186/s12865-020-00365-w |
Ejemplares similares
-
Hydroxychloroquine inhibits IL-1β production from amyloid-stimulated human neutrophils
por: Fujita, Yuya, et al.
Publicado: (2019) -
Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus
por: Matsuoka, Naoki, et al.
Publicado: (2020) -
Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022) -
T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients
por: Matsumoto, Haruki, et al.
Publicado: (2020) -
Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
por: Fujita, Yuya, et al.
Publicado: (2020)